NCT06570122 Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents
| NCT ID | NCT06570122 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Normal University |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-09-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.
Eligibility Criteria
Inclusion Criteria: 1. aged 18 and above, reside in Zhuhai for the next 6 months 2. smoke at least 1 cigarette or use e-cigarettes daily 3. have a smartphone and a WeChat account, able to use WeChat skillfully Exclusion Criteria: 1. Smokers who have communication barrier (either physically or cognitively) 2. Smokers who are currently participating in other SC programmes or services
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06570122 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06570122 currently recruiting?
Yes, NCT06570122 is actively recruiting participants. Contact the research team at xueweng@bnu.edu.cn for enrollment information.
Where is the NCT06570122 trial being conducted?
This trial is being conducted at Zhuhai, China.
Who is sponsoring the NCT06570122 clinical trial?
NCT06570122 is sponsored by Beijing Normal University. The trial plans to enroll 300 participants.